CONOLIDINE PROLEVIATE FOR JOINT PAIN TREATMENT CAN BE FUN FOR ANYONE

Conolidine’s analgesic outcomes stem from its interaction with non-opioid pain pathways. As opposed to opioids, which bind to µ-opioid receptors during the central anxious procedure, conolidine modulates alternate molecular targets. A Science Improvements analyze identified that conolidine interacts Along with the atypical chemokine receptor ACK